U.S. RESEARCH ROUNDUP- Codexis, Ionis Pharmaceuticals, Travere Therapeutics

Infinity Pharmaceuticals

31/03/2022 08:12

March 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Codexis, Ionis Pharmaceuticals and Travere
Therapeutics, on Thursday. 
    
  HIGHLIGHTS        
     * Akebia Therapeutics Inc  AKBA.O : Piper Sandler cuts to neutral from overweight
     * Codexis Inc  CDXS.O : Piper Sandler assumes coverage with overweight rating; PT $35
     * Ionis Pharmaceuticals  IONS.O : Piper Sandler assumes with overweight rating; PT $54
     * RH  RH.N : Cowen and Company cuts target price to $600 from $850
     * Travere Therapeutics  TVTX.O : Piper Sandler starts with overweight rating; PT $42
                
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order.     
     * Acutus Medical Inc  AFIB.O : Canaccord Genuity cuts target price to $2 from $3
     * Adagio Therapeutics Inc  ADGI.O : Jefferies cuts target price to $6 from $10
     * Agilon Health Inc  AGL.N : SVB Leerink raises target price to $33 from $25$
     * Akebia Therapeutics Inc  AKBA.O : Piper Sandler cuts to neutral from overweight
     * Akebia Therapeutics Inc  AKBA.O : Piper Sandler cuts target price to $2 from $8
     * Arhaus Inc  ARHS.O : Jefferies cuts target price to $16 from $17
     * Arhaus Inc  ARHS.O : Piper Sandler cuts target price to $15 from $17
     * Arhaus Inc  ARHS.O : Telsey Advisory Group raises target price to $12 from $11
     * Aveanna Healthcare Holdings Inc  AVAH.O : Jefferies cuts target price to $9 from $11
     * Aveanna Healthcare Holdings Inc  AVAH.O : RBC cuts target price to $9 from $16
     * Braze Inc  BRZE.O : JP Morgan cuts target price to $65 from $80
     * Braze Inc  BRZE.O : Piper Sandler cuts target price to $65 from $85
     * Braze Inc  BRZE.O : Raymond James cuts target price to $65 from $85
     * Celcuity Inc  CELC.O : Jefferies cuts target price to $36 from $45
     * Chewy Inc  CHWY.N : Citigroup cuts price target to $45 from $48
     * Cintas Corp  CTAS.O : Jefferies raises target price to $500 from $492
     * Clarus Therapeutics Holdings  CRXT.O : Cantor Fitzgerald cuts target price to $3 from $20
     * Codexis Inc  CDXS.O : Piper Sandler assumes coverage with overweight rating; PT $35
     * Core & Main Inc  CNM.N : RBC cuts target price to $31 from $33
     * Core & Main Inc  CNM.N : Truist Securities cuts target price to $28 from $32
     * Crinetics Pharmaceuticals Inc  CRNX.O : JP Morgan raises target price to $37 from $36
     * Cue Health Inc  HLTH.O : BTIG cuts target price to $13 from $16
     * Expensify Inc  EXFY.O : JP Morgan cuts target price to $47 from $57
     * Expensify Inc  EXFY.O : Piper Sandler cuts target price to $25 from $45
     * Five Below Inc  FIVE.O : Jefferies cuts target price to $250 from $300
     * Gan Ltd  GAN.O : Jefferies cuts target price to $10 from $22
     * HP Inc  HPQ.N : JP Morgan raises target price to $41 from $40
     * IGM Biosciences Inc  IGMS.O : Wedbush cuts target price to $58 from $67
     * Infinity Pharmaceuticals Inc  INFI.O : Truist Securities cuts target price to $4 from $12
     * Ionis Pharmaceuticals  IONS.O : Piper Sandler assumes with overweight rating; PT $54
     * Lianbio  LIAN.O : Jefferies cuts target price to $16 from $20
     * Nicolet Bankshares Inc  NCBS.O : Piper Sandler raises target price to $108 from $100
     * Nuvalent Inc  NUVL.O : JP Morgan cuts target price to $31 from $38
     * Ormat Technologies Inc  ORA.N : JP Morgan raises target price to $69 from $65
     * Paychex Inc  PAYX.O : Jefferies raises target price to $140 from $135
     * Paychex Inc  PAYX.O : JP Morgan raises target price to $125 from $121
     * Phreesia Inc  PHR.N : JP Morgan cuts target price to $42 from $51
     * Phreesia Inc  PHR.N : SVB Leerink cuts target price to $29 from $41
     * Purecycle Technologies Inc  PCT.O : Cowen and Company cuts PT to $17 from $26.50
     * PVH Corp  PVH.N : Wedbush raises target price to $89 from $85
     * Replimune Group Inc  REPL.O : Jefferies cuts target price to $49 from $64
     * RH  RH.N : Cowen and Company cuts target price to $600 from $850
     * Sailpoint Technologies Holdings Inc  SAIL.N : Canaccord Genuity raises PT to $65 from $57
     * Schlumberger NV  SLB.N : Cowen and Company raises target price to $48 from $42
     * Sempra Energy  SRE.N : JP Morgan raises target price to $164 from $155
     * Stronghold Digital Mining Inc  SDIG.O : D.A. Davidson cuts target price to $10 from $25
     * Travere Therapeutics  TVTX.O : Piper Sandler starts with overweight rating; PT $42
     * UiPath Inc  PATH.N : Credit Suisse cuts target price to $57.5 from $75
     * UiPath Inc  PATH.N : RBC cuts target price to $32 from $37
     * Uphealth Inc  UPH.N : Oppenheimer cuts target price to $6 from $10
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))